Archive: 18/06/2012

Cheaper AMD drug could lead to serious eye issues

A Queen's University study of two eye drugs used to treat wet Age-related Macular Degeneration (AMD) has determined the cheaper of the two could lead to eye inflammation, a potentially blinding adverse effect.

page 3 from 8